Subscription Pricing Could Expand Access to HIV Prevention Breakthrough While Controlling Costs

Subscription pricing could expand access to HIV prevention breakthrough while controlling costs

Figure 2 from the PURPOSE-1 trial changed the world. Between gray and red bars representing the study’s background HIV incidence and the arms randomized to receive oral pre-exposure prophylaxis (PrEP) was white space filled only by a previously unimaginable number: zero. Zero infections over one year among the 2,134 cisgender adolescent girls and young women who received the novel long-acting injectable antiretroviral lenacapavir.Read the rest…

Global Health Watch: Zambia’s Bilateral MoU, NIH Budget Cut, LEN Pricing & Access, New HIV Prevention Access Framework

This week, the global health world lost a true leader, Stephen Lewis, whose life was defined by an unwavering commitment to creating a better, more just world. Lewis’ unwavering passion and fearless advocacy continue to set the standard, reminding us that global health demands urgency, equity and accountability. This week’s issue follows that charge. It covers growing calls for transparency: from Zambia’s bilateral MoU, to the anticipated propos…